Shopping Cart No items
Call toll-free : 1-877-385-8998
Monday 18 May 2020
Spiriva (tiotropium bromide) is a prescription medication that's used to treat symptoms of asthma and chronic obstructive pulmonary disease (COPD).
But who makes Spiriva, when was it approved and how is it being used today? Here, we'll explain the answers to all those questions and more.
Spiriva is manufactured by Boehringer Ingelheim, a German pharmaceutical company founded in 1885 by Albert Boehringer in the town of Ingelheim am Rhein.
The company celebrated its 125th birthday in 2010, and is one of the top 20 pharmaceutical companies in the world as of 2019.
It's still headquartered in Ingelheim am Rhein, and employs about 50,000 people worldwide as of 2020.
Boehringer Ingelheim manufactures and markets several drugs for various therapeutic areas. These include:
Besides Spiriva, the company's other notable medications include Glyxambi (empagliflozin/linagliptin), Pradaxa (dabigatran) and Micardis (telmisartan).
In 2004, Spiriva Handihaler received its first Food and Drug Administration (FDA) approval for the treatment of COPD.
In 2014, Spiriva Respimat received FDA approval for the maintenance treatment of COPD, and in 2015 was also approved for the maintenance treatment of asthma in adults and adolescents. In 2017, it was approved for the maintenance treatment of asthma in children, too.
Both Spiriva Respimat and Handihaler contain the same medication, but they're used in different ways. While Spiriva Respimat uses a single cartridge that lasts for one month, Spiriva Handihaler requires users to insert a new capsule for each use.
Tiotropium bromide, the active ingredient in Spiriva, works by relaxing the muscles around the airways, thus allowing the user to breathe easier.
According to data gathered by ClinCalc in 2020, tiotropium is the 82nd most-prescribed drug in the U.S. In 2017 alone, 9.5 million prescriptions for the drug were written.
As a prescription drug, Spiriva has the potential to cause side effects both mild and severe. According to Spiriva's official website, some of the most common adverse effects include:
At the time of writing, there is no generic alternative to Spiriva available in the U.S. The earliest year at which such an alternative may become available is 2021, at which point some of Boehringer Ingelheim's patents on the drug will expire.
In the meantime, patients can still save money on their prescription by purchasing Spiriva Respimat or Spiriva Handihaler online from a trustworthy online pharmacy or pharmacy referral service.
Weekdays: 9:00 AM - 6:00 PM PSTWeekends: 10:00 AM - 03:00 PM PST